Inequities between provinces in treating rare diseases
According to a 2015 study by UAlberta researchers, access to drugs for rare diseases varies significantly across provinces and territories. Five provinces—Alberta, Ontario, Saskatchewan, and British Columbia—have created specific programs to decide which patients should receive coverage for orphan disease drugs. Patients in other jurisdictions can apply for coverage through the regular drug program. Criteria for who qualifies for coverage vary depending on the province, however, and health ministries don’t even agree on how to define a rare disease.